HomeCompareRS vs CAPL

RS vs CAPL: Dividend Comparison 2026

RS yields 1.61% · CAPL yields 10.21%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RS wins by $5.89M in total portfolio value· pulled ahead in Year 5
10 years
RS
RS
● Live price
1.61%
Share price
$300.49
Annual div
$4.85
5Y div CAGR
90%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.93M
Annual income
$4,946,851.97
Full RS calculator →
CAPL
CAPL
● Live price
10.21%
Share price
$20.57
Annual div
$2.10
5Y div CAGR
1.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$2,232.50
Full CAPL calculator →

Portfolio growth — RS vs CAPL

📍 RS pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRSCAPL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RS + CAPL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RS pays
CAPL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RS
Annual income on $10K today (after 15% tax)
$137.19/yr
After 10yr DRIP, annual income (after tax)
$4,204,824.17/yr
CAPL
Annual income on $10K today (after 15% tax)
$867.77/yr
After 10yr DRIP, annual income (after tax)
$1,897.63/yr
At 15% tax rate, RS beats the other by $4,202,926.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RS + CAPL for your $10,000?

RS: 50%CAPL: 50%
100% CAPL50/50100% RS
Portfolio after 10yr
$2.99M
Annual income
$2,474,542.23/yr
Blended yield
82.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RS right now

RS
Analyst Ratings
9
Buy
16
Hold
2
Sell
Consensus: Hold
Price Target
$330.00
+9.8% upside vs current
Range: $320.00 — $340.00
Altman Z
6.0
Piotroski
7/9
CAPL
Analyst Ratings
6
Buy
8
Hold
1
Sell
Consensus: Hold
Altman Z
6.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RS buys
0
CAPL buys
0
No recent congressional trades found for RS or CAPL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRSCAPL
Forward yield1.61%10.21%
Annual dividend / share$4.85$2.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR90%1.1%
Portfolio after 10y$5.93M$40.8K
Annual income after 10y$4,946,851.97$2,232.50
Total dividends collected$5.83M$16.0K
Payment frequencyquarterlyquarterly
SectorMaterialsStock
Analyst consensusHoldHold

Year-by-year: RS vs CAPL ($10,000, DRIP)

YearRS PortfolioRS Income/yrCAPL PortfolioCAPL Income/yrGap
1$11,007$306.67$11,732$1,032.13$725.00CAPL
2$12,376$599.36$13,698$1,144.14$1.3KCAPL
3$14,440$1,196.75$15,919$1,262.16$1.5KCAPL
4$17,930$2,479.30$18,419$1,385.93$489.00CAPL
5← crossover$24,651$5,466.60$21,223$1,515.18+$3.4KRS
6$39,723$13,346.12$24,358$1,649.62+$15.4KRS
7$80,692$38,188.01$27,852$1,788.92+$52.8KRS
8$224,087$137,747.25$31,735$1,932.73+$192.4KRS
9$919,042$679,268.17$36,037$2,080.71+$883.0KRS
10$5,930,227$4,946,851.97$40,792$2,232.50+$5.89MRS

RS vs CAPL: Complete Analysis 2026

RSMaterials

Reliance Steel & Aluminum Co. operates as a diversified metal solutions provider and the metals service center company in the United States, Canada, and internationally. The company distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products; and provides metals processing services to general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, and heavy industries. It also distributes non-ferrous metals products and tubular building products; and manufactures specialty extruded metals, fabricated parts, and welded components. As of December 31, 2021, the company operated a network of approximately 315 locations in 40 states in the United States and 13 in other countries. It sells its products directly to original equipment manufacturers, which primarily include small machine shops and fabricators. The company was founded in 1939 and is headquartered in Los Angeles, California.

Full RS Calculator →

CAPLStock

CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, operation of convenience stores, and ownership and leasing of real estate used in the retail distribution of motor fuels in the United States. It operates in two segments, Wholesale and Retail. The Wholesale segment engages in the wholesale distribution of motor fuels to lessee dealers, independent dealers, commission agents, and company operated retail sites. The Retail segment is involved in the sale of convenience merchandise items; and retail sale of motor fuels at company operated retail sites and retail sites operated by commission agents. As of December 31, 2021, the company distributed motor fuel on a wholesale basis to approximately 1,750 sites located in 34 states; and owned or leased approximately 1,150 sites. CrossAmerica GP LLC operates as the general partner of the company. The company was formerly known as Lehigh Gas Partners LP and changed its name to CrossAmerica Partners LP in October 2014. The company was founded in 1992 and is based in Allentown, Pennsylvania.

Full CAPL Calculator →
📬

Get this RS vs CAPL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RS vs SCHDRS vs JEPIRS vs ORS vs KORS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.